{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:29:51Z","timestamp":1791386991800,"version":"4.3.3"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["PRIMUS\/20\/MED\/010"],"award-info":[{"award-number":["PRIMUS\/20\/MED\/010"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV 260 549"],"award-info":[{"award-number":["SVV 260 549"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant Agency of the Charles University GAUK","award":["616216\/C\/2016"],"award-info":[{"award-number":["616216\/C\/2016"]}]},{"name":"EFSA-CDN","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"]}]},{"name":"National Research, Development and Innovation Office","award":["FK 128751"],"award-info":[{"award-number":["FK 128751"]}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110506","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T23:53:30Z","timestamp":1594511610000},"page":"110506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta"],"prefix":"10.1016","volume":"129","author":[{"given":"Lenka","family":"Tupova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Hirschmugl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-458X","authenticated-orcid":false,"given":"Simona","family":"Sucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Pilarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-9059","authenticated-orcid":false,"given":"Vir\u00e1g","family":"Sz\u00e9kely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-0451","authenticated-orcid":false,"given":"\u00c9va","family":"Bakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-6339","authenticated-orcid":false,"given":"Csilla","family":"\u00d6zvegy-Laczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wadsack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-7212","authenticated-orcid":false,"given":"Martina","family":"Ceckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2020.110506_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/nutrit\/nuw009","article-title":"The placenta: the forgotten essential organ of iron transport","volume":"74","author":"Cao","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.biopha.2020.110506_bib0010","doi-asserted-by":"crossref","first-page":"179827","DOI":"10.1155\/2012\/179827","article-title":"Regulation of nutrient transport across the placenta","volume":"2012","author":"Lager","year":"2012","journal-title":"J. Pregnancy"},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"Vahakangas","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-017-2286-0","article-title":"The placental barrier: the gate and the fate in drug distribution","volume":"35","author":"Tetro","year":"2018","journal-title":"Pharm. Res."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110506_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1440-1681.2006.04324.x","article-title":"Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo","volume":"33","author":"Ceckova","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/03602532.2010.512293","article-title":"Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy","volume":"43","author":"Hahnova-Cygalova","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425255.2015.1005073","article-title":"Regulation of drug transporter expression and function in the placenta","volume":"11","author":"Staud","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0045","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2020.110506_bib0050","series-title":"Guideline on the Investigation of Drug Interactions","author":"EMA","year":"2012"},{"key":"10.1016\/j.biopha.2020.110506_bib0055","series-title":"Guindance for Industry","author":"FDA","year":"2017"},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0060","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.109.160564","article-title":"Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility","volume":"331","author":"Cygalova","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2020.110506_bib0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.placenta.2008.05.001","article-title":"The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta","volume":"29","author":"Pollex","year":"2008","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00743-3","article-title":"Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein","volume":"408","author":"Ushigome","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110506_bib0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/dmd.104.003335","article-title":"Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation","volume":"33","author":"zu","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2020.110506_bib0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/17425255.3.6.819","article-title":"Drug transport across the placenta, role of the ABC drug efflux transporters","volume":"3","author":"Behravan","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0085","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00418.2002","article-title":"Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer","volume":"285","author":"Atkinson","year":"2003","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110506_bib0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0143-4004(03)00170-X","article-title":"Basal membrane localization of MRP1 in human placental trophoblast","volume":"24","author":"Nagashige","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.biopha.2020.110506_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.08.002","article-title":"Placental control of drug delivery","volume":"116","author":"Al-Enazy","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2020.110506_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2017.11.001","article-title":"Renal organic anion transporters in drug-drug interactions and diseases","volume":"112","author":"Huo","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110506_bib0105","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/17425255.2015.1069274","article-title":"Role of organic cation transporters in drug-drug interaction","volume":"11","author":"Koepsell","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2020.110506_bib0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.csbj.2019.03.002","article-title":"Current advances in studying clinically relevant transporters of the solute carrier (SLC) family by connecting computational modeling and data science","volume":"17","author":"Turkova","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/17425255.2017.1253679","article-title":"The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions","volume":"13","author":"Kovacsics","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0120","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.biopha.2020.110506_bib0125","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1113\/JP270743","article-title":"Glutamate cycling may drive organic anion transport on the basal membrane of human placental syncytiotrophoblast","volume":"593","author":"Lofthouse","year":"2015","journal-title":"J. Physiol."},{"issue":"2-3","key":"10.1016\/j.biopha.2020.110506_bib0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/plac.2002.0907","article-title":"Expression of organic anion transporting polypeptide E (OATP-E) in human placenta","volume":"24","author":"Sato","year":"2003","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.biopha.2020.110506_bib0135","doi-asserted-by":"crossref","first-page":"C263","DOI":"10.1152\/ajpcell.00333.2003","article-title":"L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2","volume":"287","author":"Lahjouji","year":"2004","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/dmd.106.011411","article-title":"Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta","volume":"35","author":"Grube","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.biopha.2020.110506_bib0145","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1124\/dmd.110.033571","article-title":"The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies","volume":"38","author":"Prouillac","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/biolre\/iox012","article-title":"Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differencesdagger","volume":"96","author":"Walker","year":"2017","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.biopha.2020.110506_bib0155","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00404-011-2183-4","article-title":"Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy","volume":"285","author":"Wang","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110506_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0005-2736(00)00189-9","article-title":"Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta","volume":"1466","author":"Wu","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0000000000000112","article-title":"Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta","volume":"28","author":"Neumanova","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/bdd.1993","article-title":"Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine","volume":"37","author":"Neumanova","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.biopha.2020.110506_bib0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.reprotox.2015.07.070","article-title":"Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir","volume":"57","author":"Neumanova","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.biopha.2020.110506_bib0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.reprotox.2018.05.008","article-title":"Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: effect on transplacental disposition in rats","volume":"79","author":"Cerveny","year":"2018","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.biopha.2020.110506_bib0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.placenta.2016.09.019","article-title":"Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate","volume":"47","author":"Reznicek","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.biopha.2020.110506_bib0190","article-title":"HIV: mother-to-child transmission","volume":"2008","author":"Volmink","year":"2008","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.biopha.2020.110506_bib0195","series-title":"Panel on Treatment of Pregnant Women With HIV Infection and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States.","author":"AIDSinfo","year":"2019"},{"issue":"17","key":"10.1016\/j.biopha.2020.110506_bib0200","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa1701666","article-title":"Birth outcomes for pregnant women with HIV using tenofovir-emtricitabine","volume":"378","author":"Rough","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110506_bib0205","series-title":"Panel on Antiretroviral Therapy and Medical Management of Children Living With HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection","author":"AIDSinfo","year":"2019"},{"issue":"10","key":"10.1016\/j.biopha.2020.110506_bib0210","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/civ587","article-title":"Maraviroc pharmacokinetics in HIV-1-infected pregnant women","volume":"61","author":"Colbers","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2020.110506_bib0215","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/jac\/dkz227","article-title":"Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study","volume":"74","author":"Piconi","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14787210.2016.1100535","article-title":"Off-label use of maraviroc in clinical practice","volume":"14","author":"Blanco","year":"2016","journal-title":"Expert Rev. Anti. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0225","first-page":"5","article-title":"Dual CCR5\/CCR2 targeting: opportunities for the cure of complex disorders","volume":"14","author":"Fantuzzi","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2020.110506_bib0230","first-page":"5447","article-title":"Maraviroc: a review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2020.110506_bib0235","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/dmd.119.087684","article-title":"Interactions between maraviroc and the Abcb1, Abcg2 and Abcc2 transporters: an important role in transplacental pharmacokinetics","volume":"47","author":"Tupova","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0240","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/s41598-018-20815-1","article-title":"Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1\/1B3 and 2B1","volume":"8","author":"Patik","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2020.110506_bib0245","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/febs.15156","article-title":"A novel fluorescence-based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third-generation P-gp inhibitors and OATP1A2","volume":"287","author":"Bakos","year":"2019","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2015.09.015","article-title":"Functional expression of the 11 human organic anion transporting polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate","volume":"98","author":"Patik","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0255","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"Mathiesen","year":"2010","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110506_bib0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1194\/jlr.P072355","article-title":"The influence of placental metabolism on fatty acid transfer to the fetus","volume":"58","author":"Perazzolo","year":"2017","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110506_bib0265","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","article-title":"Transfer across the perfused human placenta of antipyrine, sodium and leucine","volume":"114","author":"Schneider","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110506_bib0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.toxlet.2008.08.006","article-title":"Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta","volume":"182","author":"Annola","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2020.110506_bib0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2008.03133.x","article-title":"Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers","volume":"65","author":"Abel","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/dmd.117.079855","article-title":"Biosynthesis and identification of metabolites of maraviroc and their use in experiments to delineate the relative contributions of cytochrome P4503A4 versus 3A5","volume":"46","author":"Tseng","year":"2018","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.biopha.2020.110506_bib0285","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1432-0436.2008.00302.x","article-title":"Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential","volume":"76","author":"Lang","year":"2008","journal-title":"Differentiation"},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.2016.149","article-title":"GDM alters paracrine regulation of feto-placental angiogenesis via the trophoblast","volume":"97","author":"Loegl","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biopha.2020.110506_bib0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2019.02.002","article-title":"The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta","volume":"368","author":"Karahoda","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2015.08.099","article-title":"Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro","volume":"98","author":"Cihalova","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110506_bib0305","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1128\/AAC.46.11.3456-3462.2002","article-title":"Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2)","volume":"46","author":"Williams","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0310","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/adt.2011.441","article-title":"Development of a model for functional studies of ABCG2 (breast cancer resistance protein) efflux employing a standard BeWo clone (B24)","volume":"10","author":"Crowe","year":"2012","journal-title":"Assay Drug Dev. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0315","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2006.01.009","article-title":"Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer","volume":"6","author":"Modok","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6-7","key":"10.1016\/j.biopha.2020.110506_bib0320","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.placenta.2005.06.008","article-title":"MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction","volume":"27","author":"Atkinson","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.biopha.2020.110506_bib0325","first-page":"253","article-title":"In vitro methods for studying human placental amino acid transport placental villous fragments","volume":"122","author":"Greenwood","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110506_bib0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijantimicag.2019.02.018","article-title":"Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: a retrospective cohort study","volume":"54","author":"Weehuizen","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.biopha.2020.110506_bib0335","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0002-9440(10)64819-5","article-title":"Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission","volume":"157","author":"Behbahani","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2020.110506_bib0340","unstructured":"PuBChem. National Institutes of Health (NIH), Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Maraviroc#section=Octanol-Water-Partition-Coefficient) Accessed (2019\/08\/13). 2019; Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Maraviroc#section=Octanol-Water-Partition-Coefficient)."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0345","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/AAC.01821-12","article-title":"Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression","volume":"57","author":"Vinot","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2020.110506_bib0350","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2125.2008.03198.x","article-title":"Maraviroc: in vitro assessment of drug-drug interaction potential","volume":"66","author":"Hyland","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110506_bib0355","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1124\/dmd.114.060194","article-title":"CYP3A5 genotype impacts maraviroc concentrations in healthy volunteers","volume":"42","author":"Lu","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0360","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(99)00008-3","article-title":"The expression and regulation of drug metabolism in human placenta","volume":"38","author":"Pasanen","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2020.110506_bib0365","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/FPC.0b013e3283402efb","article-title":"Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism","volume":"20","author":"Siccardi","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"issue":"12","key":"10.1016\/j.biopha.2020.110506_bib0370","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1128\/AAC.01634-15","article-title":"Effects of antiviral drugs on organic anion transport in human placental BeWo cells","volume":"59","author":"Nabekura","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0375","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/dmd.118.085241","article-title":"Mechanistic evaluation of the complex drug-drug interactions of maraviroc: contribution of cytochrome P450 3A, P-glycoprotein and organic anion transporting polypeptide 1B1","volume":"47","author":"Kimoto","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0380","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00228-011-1167-4","article-title":"Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects","volume":"68","author":"Rebello","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0385","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0390","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00424-006-0160-8","article-title":"Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1\/ABCC1)","volume":"453","author":"Bakos","year":"2007","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0395","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mob.2001.113319","article-title":"Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model","volume":"185","author":"Forestier","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0400","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ejps.2009.05.005","article-title":"The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta","volume":"37","author":"Rahi","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2020.110506_bib0405","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/jps.21644","article-title":"Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice","volume":"98","author":"Coles","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110506_bib0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-291X(03)00327-9","article-title":"Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells","volume":"303","author":"Pascolo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2020.110506_bib0415","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","article-title":"P-glycoprotein in the placenta: expression, localization, regulation and function","volume":"22","author":"Ceckova-Novotna","year":"2006","journal-title":"Reprod. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110506_bib0420","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1289\/ehp.02110523","article-title":"Inorganic mercury and methylmercury in placentas of Swedish women","volume":"110","author":"Ask","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.biopha.2020.110506_bib0425","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2015.12.005","article-title":"Mercury toxicokinetics of the healthy human term placenta involve amino acid transporters and ABC transporters","volume":"340","author":"Straka","year":"2016","journal-title":"Toxicology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220306995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220306995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:20:08Z","timestamp":1760098808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220306995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":85,"alternative-id":["S0753332220306995"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110506","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110506"}}